By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) — Igenica today said it has completed a Series B financing round, raising $24 million.

The round was led by The Column Group, OrbiMed Advisors, and 5AM Ventures. The funds will be used to expand and accelerate Igenica's drug discovery and development efforts using its proteomics- and antibody-based platforms, Igenica said in a statement.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

A new analysis examines the gender gap among paper authors in the sciences and says it may take decades or more to close.

Researchers have uncovered signals of selection that may enable the Bajau people to free five hundreds of feet deep, Reuters reports.

In Science this week: paternally inherited cis-regulatory structural variants in autism, and more.

A new report outlines issues facing the implementation of personalized medicine in the UK, the Independent reports.